Squarepoint
GHDX

Squarepoint’s Genomic Health, Inc. GHDX Stock Holding History

Squarepoint’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-48,700
Closed -$3.3M – 2978
2019
Q3 		$3.3M Buy
48,700
+38,900
+397% +$2.67M 0.03% 624
2019
Q2 		$570K Sell
9,800
-29,598
-75% -$1.75M 0.01% 1590
2019
Q1 		$2.76M Sell
39,398
-616
-2% -$45.7K 0.03% 640
2018
Q4 		$2.58M Buy
40,014
+21,614
+117% +$1.52M 0.03% 597
2018
Q3 		$1.29M Sell
18,400
-10,735
-37% -$628K 0.02% 880
2018
Q2 		$1.47M Buy
29,135
+9,535
+49% +$378K 0.02% 746
2018
Q1 		$613K Buy
+19,600
New +$650K 0.01% 1006
2017
Q4 		– Sell
-7,408
Closed -$238K – 2456
2017
Q3 		$238K Buy
+7,408
New +$234K ﹤0.01% 1298

Squarepoint's GHDX Position: Q4 2019 in Review

Squarepoint sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 48,700 shares — an estimated $3.3M sold.

Squarepoint first reported a position in GHDX in Q3 2017 and held it in 8 quarters. The position peaked at $3.3M in Q3 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.

  • Squarepoint reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
  • Squarepoint sold 48,700 Genomic Health, Inc. shares in Q4 2019, an estimated $3.3M.
  • Squarepoint first reported a position in Genomic Health, Inc. in Q3 2017 and held it in 8 quarters.
  • Squarepoint's Genomic Health, Inc. position peaked at $3.3M in Q3 2019.
  • 0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.

Based on Squarepoint's 13F filing for Q4 2019, filed 14 Feb 2020.